For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
New chief executive officer
New chief executive officer

The Trust is delighted to announce the appointment of Margareth Broodkoorn (MHthSc) to the position of Chief Executive Officer, to replace retiring current CEO John Wigglesworth. Margareth was born in Hokianga Hospital and this role will fulfil a moemoea to give back to the community of her birth. Ko Ngapuhi te iwi, ko Ngati Wharara, Ngati Korokoro, me Te Pouka. She will take up her position early in 2021.
Margareth is a registered nurse, with ten years solid nursing experience before moving into various health management positions, including with Hauora Hokianga from 2008 to 2010, and Director of Nursing and Midwifery with Northland DHB to 2019. She is currently Chief Nursing Officer of NZ with Ministry of Health. But Hokianga has a strong calling and Margareth is keen to bring her skills home and be near her whanau. Margareth has a strong commitment to Te Tiriti o Waitangi in addressing health inequity for Maori and access to health services for all consumers.